Basel Medical adds three directors, two resign

BMGL says the new directors, who hold no beneficial shares today, are expected to strengthen strategic leadership, corporate governance, and support its next growth phase.

Rhea-AI Filing Summary

Basel Medical Group Ltd (BMGL) reports board changes. Directors Fung Keng Leong (Raymond) and Tan Boon Chye (Darren) have stepped down from the board with immediate effect, while Darren Tan continues as chief commercial officer. Three new directors have joined the board: Yang Xinwen, Cao Juan, and Frederick Hong Shieh Ming, who becomes an independent director. The company states that none of the new directors currently have beneficial ownership of its shares. The new appointees bring experience in healthcare, business development, operations, capital markets, and real estate advisory, which the company believes will strengthen strategic leadership, corporate governance, and support its next phase of business development and growth.

Key Terms

independent director, beneficial ownership, corporate governance, capital markets

4 terms

independent director regulatory

"has joined the board as an independent director"

An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.

beneficial ownership financial

"None of the new directors have any beneficial ownership in the shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

corporate governance regulatory

"corporate governance initiatives"

Corporate governance is the system of rules, roles and oversight that determines how a company is directed and controlled, including the responsibilities of its board, executives and shareholders. Like the steering wheel and map for a car trip, it shapes decisions, sets checks on power and defines who can hold leaders accountable; strong governance reduces risk, builds trust and helps investors judge whether a company is likely to protect capital and deliver reliable returns.

capital markets financial

"capital markets and investment advisory"

Capital markets are places where people and organizations buy and sell long-term investments like stocks and bonds. They help connect those who need money to grow or fund projects with investors looking to earn returns over time. For investors, capital markets are important because they offer opportunities to invest, save, and grow their wealth through a variety of financial assets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board changes did Basel Medical Group Ltd (BMGL) announce in the September 2026 Form 6-K?

Two directors, Fung Keng Leong (Raymond) and Tan Boon Chye (Darren), stepped down from the board with immediate effect. They were replaced by three new directors: Yang Xinwen, Cao Juan, and Frederick Hong Shieh Ming, with Mr. Hong serving as an independent director.

Does Basel Medical Group Ltd (BMGL) state that the new directors own any company shares?

No. The company states that none of the new directors have any beneficial ownership in the shares of Basel Medical Group Ltd at the time of their appointment to the board.

What is Darren Tan’s role at Basel Medical Group Ltd (BMGL) after leaving the board?

After stepping down as a director, Darren Tan remains the chief commercial officer of Basel Medical Group Ltd. Only his board role changed; his executive management position with the company continues.

What experience does new director Yang Xinwen bring to Basel Medical Group Ltd (BMGL)?

Yang Xinwen has experience in healthcare, elderly care, emergency-response training, market development and business operations. He previously served as market operations president of Qilu Dakang Digital Technology and is expected to support BMGL’s healthcare business development and market expansion.

Who is the new independent director at Basel Medical Group Ltd (BMGL) and what is his background?

Frederick Hong Shieh Ming is the new independent director. He has over 24 years of capital markets and real estate experience in Singapore, including roles in securities dealing and property advisory, and currently serves as an associate senior marketing director with Huttons Asia.

How does Basel Medical Group Ltd (BMGL) describe the purpose of these board changes?

The company and its management believe the changes will broaden the board’s experience across healthcare, business operations, commercial development, capital markets and investment advisory, and are intended to strengthen strategic leadership and corporate governance to support the next phase of business development and growth.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 06:54 AM EDT Accepted by SEC EDGAR 09/02/2026 - 06:54 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2026

Commission File Number: 001-42527

Basel Medical Group Ltd

6 Napier Road,

Unit #02-10/11 Gleneagles Medical Centre

Singapore 258499

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Changes of Directors

The board of directors of Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) has approved certain changes to its board membership.

The Company’s current directors, Mr. Fung Keng Leong (Raymond) and Mr. Tan Boon Chye (Darren) have stepped down from the board with immediate effect. Mr. Darren Tan will remain in his role as the chief commercial officer of the Company. In conjunction, the outgoing directors have nominated three new appointees who have joined the board of directors, being Mr. Yang Xinwen, Ms. Cao Juan, and Mr. Frederick Hong. None of the new directors have any beneficial ownership in the shares of the Company.

Mr. Yang Xinwen has joined the board as a director. Mr. Yang has experience in healthcare, elderly care, emergency-response training, market development and business operations. He previously served as market operations president of Qilu Dakang Digital Technology Co., Ltd., where he was responsible for market strategy, business development and team management in the digital healthcare sector. He has also served as an expert adviser to the Health Committee of Lions Clubs International (Guangdong Chapter) since 2018. In his role with the Company, Mr. Yang is expected to contribute to the Company’s healthcare business development, strategic planning and market expansion initiatives.

Mr. Yang is also the deputy editor-in-chief of the Macau Global Chinese Business Journal. Mr. Yang graduated from the Bachelor of Law, Jiangxi Provincial Party School in Jiangxi, China.

Ms. Cao Juan has joined the board as a director. Ms. Cao has more than 15 years of experience in business development, sales, channel management, project execution, customer relationship management and internal administration. From 2023 to 2025, she served as business manager of Chengdu Huiya Innovation Education Research Institute, where she was responsible for business operations, market development, customer-resource integration, commercial negotiations and project delivery. She previously held senior business-management positions with Sichuan Zizhihui Business Consulting Co., Ltd. and Sichuan Houzhong Culture Communication Co., Ltd. In her role with the Company, Ms. Cao is expected to contribute to the Company’s commercial development, operational management, internal coordination and corporate governance initiatives.

Ms. Cao graduated from Sichuan Normal University, China, Law School, with a major in law.

Mr. Frederick Hong Shieh Ming has joined the board as an independent director. Mr. Hong is a client-facing capital markets and real estate professional with over 24 years of experience across securities dealing and residential/investment property advisory in Singapore. He currently serves as an associate senior marketing director with Huttons Asia in Singapore, and previously held roles with DTZ Property, Kim Eng Securities and OCBC Securities. Mr. Hong holds a real estate salesperson licence from the Council for Estate Agencies, Singapore and also holds a diploma in finance from the Institute of Banking and Finance (IBF), Singapore.

The Company and its management team believes that the Board changes will broaden the Board’s collective experience across healthcare, business operations, commercial development, capital markets and investment advisory. The appointments are intended to strengthen the Company’s strategic leadership and corporate governance capabilities and to support the Company’s next phase of business development, operational expansion and long-term growth.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Basel Medical Group Ltd
	By:	/s/ Alton Neo Chun How
	Name:	Alton Neo Chun How
	Title:	Interim Chief Financial Officer
Date: September 2, 2026